Lanton Law Quoted in Pharmacy Times Interview on Drug Pricing Reforms Amid the Repeal of Executive Order 14087

healthcareFDACMSlife sciencesMedicarepharmacypharmaceuticalspharmacy benefit managerPharmacy TimesPhRMA
Written By Ron Lanton

Lanton Law was quoted in the Pharmacy Times Article titled "Reversal of Executive Order (EO) 14087 Raises Questions About Future Drug Pricing Reforms.” We discuss the EO and how pharmacists are impacted. The article can be viewed here.

Ron Lanton
Previous

Lanton Law Speaks with Pharmaceutical Executive on Navigating NIH Funding Cuts, Diversity Bans, and Tariff Challenges
Next

New Presidential Executive Order on Artificial Intelligence Released